Skip to main content

Table 5 The clinical data analysis of COVID-19 confirmed patients

From: Rapid identification of COVID-19 severity in CT scans through classification of deep features

Characteristics Total cases (N = 202) Non-severely ill (N = 161) Severely ill (N = 41) P
Clinical data
 Gender (male) 110 (54.5%) 82 (50.9%) 28 (68.3%) 0.01
 Age (mean ± S.D., year) 46.4 ± 15.554 43.7 ± 14.600 57.0 ± 14.782 < 0.001
 Coexisting Illness 53 (26.2%) 30 (18.6%) 23 (56.1%) < 0.001
Symptoms
 Fever 157 (77.7%) 118 (73.3%) 39 (95.1%) 0.523
 Cough 109 (54.0%) 82 (50.9%) 27 (65.9%) 0.087
 Sputum production 48 (23.8%) 38 (23.6%) 10 (24.4%) 0.916
 Sore throat 17 (8.4%) 15 (9.3%) 2 (4.9%) 0.361
 Nausea/headache 11 (5.4%) 9 (5.6%) 2 (4.9%) 0.858
 Myalgia or arthralgia 15 (7.4%) 12 (7.5%) 3 (7.3%) 0.976
 Shortness of breath 16 (7.9%) 11 (6.8%) 5 (12.2%) 0.256
 Others 8 (4.0%) 8 (5.0%) 0 (0%) 0.145
Laboratory findings
 Increase of CRP 129 (63.9%) 92 (57.1%) 37 (90.2%) < 0.001
 WBCs abnormalitya 73 (36.1%) 50 (31.1%) 23 (56.1%) 0.011
 Lymphocytes abnormalitya 109 (54.0%) 76 (47.2%) 33 (80.5%) < 0.001
Fever
 High fever 12 (5.9%) 2 (1.2%) 10 (24.4%) < 0.001
 Low fever 145 (71.8%) 116 (72.0%) 29 (70.7%) 0.867
Travel or contact history 92 (45.5) 79 (49.1%) 13 (31.7%) 0.046
  1. Normal body temperature: 36.3 °C–37.2 °C; Normal value of CPR: 0–10 mg/l; Normal value of WBCs: 3.5–9.5 × 109/l; Normal ratio of lymphocytes: 20%–50%; High fever (≥ 39.0 °C)
  2. aIncrement or reduction